Survival Outcomes among Human Epidermal Growth Factor Receptor 2- (HER2-) Positive Breast Cancer Patients at Kenyatta National Hospital

INTRODUCTION: HER2-positive breast cancer is associated with poor outcomes and higher mortality rates than other breast cancer subtypes. The advent of trastuzumab has significantly changed the natural history of HER2-positive breast cancer. However, it is not an affordable treatment option in sub-Sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuwei, Gloria, Degu, Amsalu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694968/
https://www.ncbi.nlm.nih.gov/pubmed/34956679
http://dx.doi.org/10.1155/2021/3115727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694968/
https://www.ncbi.nlm.nih.gov/pubmed/34956679
http://dx.doi.org/10.1155/2021/3115727

Ejemplares similares